Malaria — Epidemiology, Treatment, and Prevention

In this documentary video from the _New England Journal of Medicine,_ physicians and
scientists from across the world discuss the epidemiology of malaria and outline
key strategies for prevention and treatment of the disease.

The narrative takes a deep dive into prevention of the disease, including
strategies to control mosquito vectors, new vaccines, and monoclonal antibodies.
The video anticipates the challenges of eliminating malaria, given the emergence
of drug-resistant strains, and looks to promising new therapies on the horizon.

For further reading, the following articles, referenced in this video, are
available at the _Journal_’s website: A Malaria Vaccine for Africa — An Important
Step in a Century-Long Quest (P.L. Alonso and K.L. O’Brien, https://www.nejm.org/doi/full/10.1056/NEJMp2116591 ),
in the March 17, 2022, issue; Safety and
Efficacy of a Monoclonal Antibody against Malaria in Mali (K. Kayentao et al.,
https://www.nejm.org/doi/full/10.1056/NEJMoa2206966 )
in the November 17,
2022, issue; and Low-Dose Subcutaneous or Intravenous Monoclonal Antibody
to Prevent Malaria (R.L. Wu et al., https://nejm.org/doi/full/10.1056/NEJMoa2203067 ),
in the November 17, 2022, issue.

This video includes footage and photos provided by the Global Fund to Fight
AIDS, Tuberculosis, and Malaria; MMV Medicines for Malaria Venture; Caz
Tanner; Suphak Nosten for Shoklo Malaria Research Unit; and Saw HTEE K
Paung for Shoklo Malaria Research Unit.

The _New England Journal of Medicine_ is the world’s leading general medical
journal. Continuously published for over 200 years, the _Journal_ publishes
peer-reviewed research along with interactive clinical content for physicians,
educators, and the global medical community at https://NEJM.org.

00:00 Chapter 1: Why haven’t we solved it?
04:41 Chapter 2: Modified mosquitoes
09:10 Chapter 3: Vaccines, monoclonal antibodies, and antimalarial drugs
12:08 Chapter 4: The threat of drug resistance
Be the first to comment